Increasing prevalence of breast cancer across the globe, rising government fund for ongoing research on breast cancer, and increasing public awareness about cancer are key factors fueling global market growth
Increasing prevalence of breast cancer across the globe, rising government fund for ongoing research on breast cancer, and increasing public awareness about cancer are key factors fueling global market growth
The global mammography market is expected to reach USD 3.4 Billion in 2028 and register a steady revenue CAGR of 8.9% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth are increasing number of screening programs and campaigns to create awareness about breast cancer, improving healthcare infrastructure and facilities, and technological advancements in breast imaging techniques.
Mammography is a specialized medical imaging system used for examining breast for detection of breast cancer and diseases. Rising prevalence of breast cancer across the globe is resulting in increasing demand for enhanced breast imaging systems. In 2020, around 2.3 Million women are diagnosed with breast cancer globally. Some of the common reasons associated with breast cancer are high consumption of alcohol, obesity, lack of physical activities, and aging. Factors such as rapid growth of geriatric population, increasing investments in research & development activities, improving reimbursement schemes, rising increasing healthcare spending, and increasing awareness about early screening and diagnosis of breast cancer are boosting global market growth. In addition, increasing demand for advanced breast cancer screening and diagnostic tools in hospitals, ambulatory care, and diagnostic centers, and increasing investments for developing advanced mammograms are factors expected to fuel market growth in the coming years.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2617
However, high initial investments, unawareness about mammography systems and early breast cancer diagnosis and treatment in remote areas, and side effects of excess radiation exposure are key factors that could hamper growth of the mammography market to a certain extent during the forecast period.
Some key highlights of the report:
- Based on technology, the breast tomosynthesis market is expected to register fastest revenue CAGR over the forecast period. Fast revenue growth is attributed to factors such as increasing demand for technologically advanced breast cancer detecting systems, high patient pool, and continuous technological advancements in breast cancer diagnostic tools.
- Based on usage, the screening segment is expected to account for larger revenue share between 2021 and 2028 owing to factors such as large patient pool, rising risks of breast cancer, increasing awareness about screening, and increasing demand for advanced screening mammograms in various medical centers.
- Among the end use segment, the ambulatory surgical centers segment is expected to register rapid revenue growth over the forecast period. Factors such as increasing incidence of breast cancer, rising public awareness about early screening, diagnosis, and treatment, increasing healthcare expenditure and availability of cost effective services are supporting segment revenue growth.
- The mammography market in Europe is expected to register significantly high revenue growth over the forecast period. Factors such as rising incidence of breast cancer, rising public awareness about breast cancer risks, and importance of early diagnosis and treatment, presence of well-developed healthcare infrastructure availability of advanced mammography systems, and increasing investments in R&D activities are fueling market growth in Europe.
- The Asia Pacific mammography market revenue is expected to expand at a rapid rate over the forecast period owing to factors such as increasing prevalence of breast cancer, improving healthcare facilities, rising healthcare spending, and increasing number of awareness programs about breast health and cancer.
- Hologic Inc., Fujifilm Holdings Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica S.p.A., I.M.S. Srl, Analogic Corporation, Canon Medical System Corporation, Mindray Medical International Limited, Planmed Oy (Planmeca Oy), Carestream Health (Onex Corporation), Konica Minolta Inc., Metaltronica S.p.A., and Koninklijke Philips N.V are key players profiled in the global mammography market report.
Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/2617
For the purpose of this report, Reports and Data has segmented the global mammography market based on product, technology, usage, end use, and region:
Product Outlook (Revenue, USD Billion; 2018 – 2028)
- Film Screen Systems
- Digital Systems
- Analog Systems
- Biopsy Systems
- 3D Systems
Technology Outlook (Revenue, USD Billion; 2018 – 2028)
- Breast Tomosynthesis
- Analog Mammography
- Digital Mammography
- Others
Usage Outlook (Revenue, USD Billion; 2018 – 2028)
- Screening
- Diagnostic
End Use Outlook (Revenue, USD Billion; 2018 – 2028)
- Hospitals
- Diagnostic and Cancer Specialty Centers
- Ambulatory Surgical Centers
- Others
Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/2617
Regional Outlook (Revenue, USD Billion, 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa